Abstract
This chapter first covers a historical overview of the development of evidence-based medicine. It then describes the first and second principles of EBM: (1) there exists a hierarchy of evidence and not all evidence is the same; users of comparative effectiveness research (CER) need to have different levels of confidence in the evidence based on its risk of bias, and (2) evidence alone is not sufficient for clinical practice; other factors such as patient values and preferences and clinical context need to be included in the process of decision-making. The chapter transitions to describe how the framework of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) allows CER evidence users to practically apply the two principles of EBM. GRADE gives a quality rating of CER evidence and transforms this evidence to a clinical recommendation that incorporates nonevidence factors. Diagnostic studies, a unique type of CER, are also subject to the same EBM framework. Finally, a case study is described to demonstrate the use of EBM and CER principles to translate a clinical prediction rule into practice using shared decision-making. This case study exhibits how EBM and CER can be utilized to provide evidence-based and individualized patient care.
References
Als-Nielsen B, Chen W, et al. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA. 2003;290(7):921–8.
Bhandari M, Busse JW, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ. 2004;170(4):477–80.
Brenner DJ. Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatr Radiol. 2002;32(4):228–31. discussion 242–224.
Brenner DJ, Hall EJ. Computed tomography–an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277–84.
Breslin M, Mullan RJ, et al. The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes. Patient Educ Couns. 2008;73(3):465–72.
Casey ET, Gupta BP, et al. The dose of continuous renal replacement therapy for acute renal failure: a systematic review and meta-analysis. Ren Fail. 2010;32(5):555–61.
Domecq Garces JP, Prutsky Lopez G, et al. Eliciting patient perspective in patient-centered outcomes research: a meta narrative systematic review. A report prepared for the Patient-Centered Outcomes Research Institute. Patient Centered Outcome Research Institute. 2012. http://www.pcori.org/assets/Eliciting-Patient-Perspective-in-Patient-Centered-Outcomes-Research-A-Meta-Narrative-Systematic-Review.pdf
Dunlay SM, Eveleth JM, et al. Medication adherence among community-dwelling patients with heart failure. Mayo Clin Proc. 2011;86(4):273–81.
Egger M, Davey Smith G, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Ewald B, Ewald D, et al. Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction. Intern Med J. 2008;38(2):101–13.
Ferreira-Gonzalez I, Busse JW, et al. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ. 2007;334(7597):786.
Flynn D, Knoedler MA, et al. Engaging patients in health care decisions in the emergency department through shared decision-making: a systematic review. Acad Emerg Med. 2012;19(8):959–67.
Gandhi GY, Murad MH, et al. Patient-important outcomes in registered diabetes trials. JAMA. 2008;299(21):2543–9.
Guyatt G, Haynes B, et al. The philosophy of evidence based medicine. In: Rennie D, Guyatt G, Meade M, Cook D, editors. Users’ guides to the medical literature. New York: McGraw-Hill; 2008a.
Guyatt GH, Oxman AD, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008b;336(7650):924–6.
Guyatt GH, Oxman AD, et al. GRADE guidelines: 7. Rating the quality of evidence–inconsistency. J Clin Epidemiol. 2011;64(12):1294–302.
Hayward RA, Kent DM, et al. Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med Res Methodol. 2006;6:18.
Hess EP, Knoedler MA, et al. The chest pain choice decision aid: a randomized trial. Circ Cardiovasc Qual Outcomes. 2012;5(3):251–259.
Irwig L, Macaskill P, et al. Bias in meta-analysis detected by a simple, graphical test. Graphical test is itself biased. BMJ. 1998;316(7129):470; author reply 470–471.
Karanicolas PJ, Montori VM, et al. A new “mechanistic-practical” framework for designing and interpreting randomized trials. J Clin Epidemiol. 2009;62(5):479–84.
Kastelein JJ, Akdim F, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008;358(14):1431–43.
Kline JA, Johnson CL, et al. Pretest probability assessment derived from attribute matching. BMC Med Inform Decis Mak. 2005;5:26.
Kline JA, Zeitouni RA, et al. Randomized trial of computerized quantitative pretest probability in low-risk chest pain patients: effect on safety and resource use. Ann Emerg Med. 2009;53(6):727–35. e721.
Kuppermann N, Holmes JF, et al. Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study. Lancet. 2009;374(9696):1160–70.
Lau J, Ioannidis JP, et al. The case of the misleading funnel plot. BMJ. 2006;333(7568):597–600.
Laupacis A, Sekar N, et al. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA. 1997;277(6):488–94.
Lewis EJ, Hunsicker LG, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851–60.
Maisel AS, Krishnaswamy P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161–7.
McGinn TG, Guyatt GH, et al. Users’ guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA. 2000;284(1):79–84.
McKelvie RS, Moe GW, et al. The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol. 2013;29(2):168–81.
Mitchell AM, Garvey JL, et al. Prospective multicenter study of quantitative pretest probability assessment to exclude acute coronary syndrome for patients evaluated in emergency department chest pain units. Ann Emerg Med. 2006;47(5):447.
Moe GW, Howlett J, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation. 2007;115(24):3103–10.
Montori VM, Breslin M, et al. Creating a conversation: insights from the development of a decision aid. PLoS Med. 2007;4(8):e233.
Montori VM, Guyatt G, Kim S, et al. Which design for which question? An exploration toward a translation table for comparative effectiveness research. J Compar Effect Res. 2012;1(3):271–279.
Mueller C, Scholer A, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350(7):647–54.
Murad MH, Montori VM, et al. Incorporating patient preferences in evidence-based medicine. JAMA. 2008;300(21):2483. author reply 2483–2484.
Murad MH, Rizvi AZ, et al. Comparative effectiveness of the treatments for thoracic aortic transection. J Vasc Surg. 2011;53(1):193–9. e191–121.
Murad MH, Drake MT, et al. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 2012;97:1871.
Niska R, Bhuiya F, et al. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Rep. 2010;6(26):1–31.
Phelps MA, Levitt MA. Pretest probability estimates: a pitfall to the clinical utility of evidence-based medicine? Acad Emerg Med. 2004;11(6):692–4.
Sackett D, Straus S, et al. Evidence-based medicine: how to practice and teach EBM. London: Churchill Livingstone; 2000.
Scirica BM. Acute coronary syndrome: emerging tools for diagnosis and risk assessment. J Am Coll Cardiol. 2010;55(14):1403–15.
Shah ND, Mullan RJ, et al. Translating comparative effectiveness into practice: the case of diabetes medications. Med Care. 2010;48(6 Suppl):S153–8.
Wang AT, McCoy CP, et al. Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ. 2010;340:c1344.
Weymiller AJ, Montori VM, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med. 2007;167(10):1076–82.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this entry
Cite this entry
Murad, M.H., Hess, E.P., Montori, V.M. (2015). Evidence-Based Medicine and Comparative Effectiveness Research. In: Levy, A., Sobolev, B. (eds) Comparative Effectiveness Research in Health Services. Health Services Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7586-7_20-1
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7586-7_20-1
Received:
Accepted:
Published:
Publisher Name: Springer, Boston, MA
Online ISBN: 978-1-4899-7586-7
eBook Packages: Springer Reference MedicineReference Module Medicine